Status:
COMPLETED
Neuro 1 vs. Neuro 2 Sound Processors
Lead Sponsor:
Oticon Medical
Conditions:
Hearing Loss, Sensorineural
Cochlear Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study evaluates the benefit of Neuro 1 sound processor upgrade in speech perfomance in adults. Half of participants will be tested with Neuro 1 first and Neuro 2, while the other half will be tes...
Detailed Description
The Neuro 1 processor represented a technological advancement over past models, particularly in detecting the environment and automatically adjusting to the sound environment. A second version of the ...
Eligibility Criteria
Inclusion
- written informed consent
- primary implantation
- subject having participated to previous Neuro 1 sound processor study in Canada
- fluent in English, including reading and writing.
Exclusion
- psychologically unsuitable
- unrealistic expectations regarding possible benefits, risks, and limitations that are inherent to the device
- non compliant with all investigational requirements.
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03756337
Start Date
November 1 2019
End Date
January 10 2020
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Hearing and Speech centres
Halifax, Canada